| Drug Name |
Cefotaxime sodium |
| Drug ID |
BADD_D00391 |
| Description |
Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy. Cefotaxime sodium is marketed under various trade names including Claforan (Sanofi-Aventis). |
| Indications and Usage |
Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery. |
| Marketing Status |
approved |
| ATC Code |
J01DD01 |
| DrugBank ID |
DB00493
|
| KEGG ID |
D00919
|
| MeSH ID |
D002439
|
| PubChem ID |
10695961
|
| TTD Drug ID |
D0D1HA
|
| NDC Product Code |
52946-0826 |
| UNII |
258J72S7TZ
|
| Synonyms |
Cefotaxime | Cephotaxim | Cefotaxim | Biosint | Cefotaxime Sodium | Sodium, Cefotaxime | Cefradil | Taporin | Fotexina | HR-756 | HR 756 | HR756 | Kendrick | Ru-24756 | Ru 24756 | Ru24756 | Benaxima | Claforan | Primafen | Klaforan |
